Phase 3 data show Deuruxolitinib significantly improve scalp hair regrowth in Alopecia Areata
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
Expands robotics to 20+ specialities
Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million
Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Marksans' OTC Famotidine Tablets USP are acid reducers
Subscribe To Our Newsletter & Stay Updated